The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis

Autor: Milla Johanna Kviatkovsky, Marc C. Hochberg, Florence Tubach, Nicholas Bellamy, David T. Felson, Claire Bombardier, marco Matucci-Cerinic, Désirée van der Heijde, Mazime Dougados, Robert Landewe, Isabelle Logeart, Emilio Martín-Mola, Hassane Awada, Mart van der Laar, Najia Hajjaj-Hassouni, Philippe Ravaud, Sofia Ramiro

Publikováno v: Journal of Rheumatology, 43(9), 1680-1686
Kviatkovsky, M J, Ramiro, S, Landewe, R, Dougados, M, Tubach, F, Bellamy, N, Hochberg, M, Ravaud, P, Martin-Mola, E, Awada, H, Bombardier, C, Felson, D, Hajjaj-Hassouni, N, Logeart, I, Matucci-Cerinic, M, van der Laar, M & van der Heijde, D 2016, ' The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis ', The Journal of rheumatology, vol. 43, no. 9, pp. 1680-1686 . https://doi.org/10.3899/jrheum.151244

Objective.To establish cutoffs for the minimum clinically important improvement (MCII) and the patient-acceptable symptom state (PASS) for the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Bath Ankylosing Spondylitis Functional

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd1c892b2b9dcf3f52a9d1b6fe5a5ebd
https://hdl.handle.net/1887/112367